advanced search

Welcome: Guest

log in

Orthofix International N.V. Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 49
ISBN Number not applicable
Product Code GMD04631
Buy this product or for assistance call +44 20 7060 7474

Summary

This report is an insightful source for data, analysis and strategic insights into a Orthofix International N.V.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Cardiovascular Devices
    • 2.5 Industry Outlook - Orthopedic Devices
    • 2.6 SWOT Snapshot
  • 3 Orthofix International N.V. Pipeline Products
    • 3.1 Orthofix International N.V. Product Pipeline Analysis
      • 3.1.1 Orthofix International N.V. Pipeline Products By Equipment Type
      • 3.1.2 Orthofix International N.V. Pipeline Products By Development Stage
      • 3.1.3 Orthofix International N.V. Pipeline Products By Therapy Area
      • 3.1.4 Orthofix International N.V. Pipeline Products By Clinical Trials
      • 3.1.5 Orthofix International N.V. Pipeline Products By News Summary
    • 3.2 Advent Cervical Disc
      • 3.2.1 Product Description
      • 3.2.2 Product Status
      • 3.2.3 Clinical Trials
      • 3.2.4 Product Milestone
    • 3.3 Centro Nail System
      • 3.3.1 Product Description
      • 3.3.2 Product Status
    • 3.4 Device for degenerative spinal disc disease
      • 3.4.1 Product Description
      • 3.4.2 Product Status
  • 4 Business Description
    • 4.1 Business Overview
      • 4.1.1 Financials
    • 4.2 Blackstone
      • 4.2.1 Overview
      • 4.2.2 Financials
      • 4.2.3 Capital Expenditure
      • 4.2.4 Market View
      • 4.2.5 Key Strategies
    • 4.3 Breg
      • 4.3.1 Overview
      • 4.3.2 Financials
      • 4.3.3 Capital Expenditure
      • 4.3.4 Market View
      • 4.3.5 Key Strategies
    • 4.4 Domestic
      • 4.4.1 Overview
      • 4.4.2 Capital Expenditure
      • 4.4.3 Market View
      • 4.4.4 Key Strategies
    • 4.5 International
      • 4.5.1 Overview
      • 4.5.2 Financials
      • 4.5.3 Capital Expenditure
    • 4.6 Major Products and Services
      • 4.6.1 Overview
  • 5 History
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Company Statement
  • 9 Locations And Subsidiaries
    • 9.1 Head Office
    • 9.2 Other Locations & Subsidiaries
  • 10 Financial Deals Landscape
    • 10.1 Acquisition
      • 10.1.1 Orthofix Acquires Blackstone Medical
      • 10.1.2 Orthofix Acquires International Medical Supplies
    • 10.2 Partnership
      • 10.2.1 Orthofix Signs An Agreement With Berkeley Advanced Biomaterials
  • 11 Recent Developments
    • 11.1 Product Announcements
      • 11.1.1 Oct 03, 2007 Orthofix International Acquires InSWing Interspinous Process Spacer
      • 11.1.2 Jun 13, 2007 Orthofix Announces First Surgical Procedure Using Advent Cervical Disc
      • 11.1.3 Sep 22, 2005 Outcome after surgery of distal radius fractures: no differences between external fixation and ORIF
      • 11.1.4 Mar 17, 2004 Orthofix International NV (OFIX) Receives FDA Notification Of Acceptance For Cervical-Stim PMA Application
      • 11.1.5 Dec 07, 2006: Orthofix Signs Agreement With UnitedHealthcare
    • 11.2 Financial Announcements
      • 11.2.1 May 01, 2008: Orthofix Declares Q1 2008 Results
      • 11.2.2 Feb 21, 2008: Orthofix Declares Q4 2007 Results
      • 11.2.3 Nov 06, 2007: Orthofix Reports Q3 2007 Results
      • 11.2.4 Aug 07, 2007: Orthofix Reports Q2 2007 Results
      • 11.2.5 May 08, 2007: Orthofix Reports Q1 2007 Results
      • 11.2.6 Mar 06, 2007: Orthofix Reports Q4 2006 Results
      • 11.2.7 Oct 26, 2006: Orthofix Reports Q3 2006 Results
      • 11.2.8 Jul 27, 2006: Orthofix Reports Q2 2006 Results
    • 11.3 Other Significant Developments
      • 11.3.1 Apr 04, 2008: Orthofix CFO Resigns
      • 11.3.2 Nov 06, 2007: Orthofix Appoints CFO
      • 11.3.3 Dec 11, 2006: Orthofix Appoints CEO To The Board
      • 11.3.4 Oct 24, 2006: Orthofix Appoints New President
  • 12 Appendix
    • 12.1 Methodology
      • 12.1.1 Coverage
      • 12.1.2 Secondary Research
      • 12.1.3 Primary Research
      • 12.1.4 Expert Panel Validation
    • 12.2 Contact Us
    • 12.3 About Global Markets Direct
    • 12.4 Disclaimer
  • List of Tables
    • Table 1: Orthofix International N.V.,Key Facts, 2006
    • Table 2: Orthofix International N.V. Pipeline Products by Equipment Type
    • Table 3: Orthofix International N.V. Pipeline Products By Development Stage
    • Table 4: Orthofix International N.V. Pipeline Products By Therapy Area
    • Table 5: Orthofix International N.V. Pipeline Products By Clinical Trials
    • Table 6: Orthofix International N.V. Pipeline Products By News Summaries
    • Table 7: Orthofix International N.V., Key Employees, 2006
    • Table 8: Orthofix International N.V., Subsidiaries
  • List of Figures
    • Figure 1: Global Markets Direct Methodology
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Product features / use
Scope Expert Insight/Opinion yes
Features Primary Research Data yes

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

Oncology Market & Patient Access

14 Dec 09 to 16 Dec 09
Prague, Czech Republic
view summary >>